Wealth Preservation Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Wealth Preservation Advisors's BMY Position: Q1 2026 in Review
Wealth Preservation Advisors increased its Bristol-Myers Squibb (BMY) stake by 6.1% in Q1 2026, buying an estimated $8.57K and bringing the position to 2,543 shares worth $154K. The position accounts for 0.13% of the portfolio, ranked #78.
Wealth Preservation Advisors first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Wealth Preservation Advisors held 2,543 shares of Bristol-Myers Squibb worth $154K as of Q1 2026.
- Wealth Preservation Advisors bought 147 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.57K.
- Bristol-Myers Squibb made up 0.13% of Wealth Preservation Advisors's portfolio in Q1 2026, its #78 holding.
- Wealth Preservation Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.